Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Checkmate Pharmaceuticals (CMPI)
NASDAQ:CMPI
Holding CMPI?
Track your performance easily
Clinical-stage biotechnology company Checkmate Pharmaceuticals Inc. reported data from its Phase 1b trial evaluating the combination of vidutolimod and pembrolizumab for the treatment of advanced anti-PD-1 refractory melanoma. Checkmate Pharmaceuticals’
...Read more
CMPI News on the Web
Yahoo Finance
Neutral
Benzinga
Neutral
TipRanks News
Neutral
Investing.com
Neutral
Investing.com
Neutral
The Motley Fool
Neutral
The Motley Fool
Neutral
Benzinga
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is CMPI’s Media Buzz Sentiment?
Currently, no data Available
What is CMPI’s weekly average amount of articles?
Currently, no data Available
What is CMPI’s News Sentiment?
Currently, no data Available